Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2023/06/054440
CTRI/2023/06/054440
Completed
未知

A Prospective Observational Study to Assess the Efficacy & Safety of Sodium-glucose Cotransporter-2(SGLT2) Inhibitors as an Add-On drug to other Oral Hypoglycemic Agents in Reducing Glycated Hemoglobin and Weight in Type 2 Diabetes Mellitus at a Tertiary Care Hospital in Jaipur. - SWAG

Dr Mahima Makhija0 sites90 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: E119- Type 2 diabetes mellitus without complications

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Sponsor
Dr Mahima Makhija
Enrollment
90
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
February 15, 2024
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
Dr Mahima Makhija

Eligibility Criteria

Inclusion Criteria

  • •1\.Patients \>18 years of age.
  • •2\.Patients of Type 2 DM fulfilling criteria of Type 2 DM according to American Diabetes Association (ADA) guidelines.
  • •3\.Patients with Type 2 DM on other OHAs.
  • •4\.T2DM Patients with other Chronic Cardiovascular issues like HTN, Heart Failure and CAD

Exclusion Criteria

  • •1\.Patients with eGFR \<60 mL/min/1\.73m2\.
  • •2\.Pregnant females.
  • •3\.Patients not filling the criteria of Type 2 DM according to ADA guidelines.
  • •4\.Patients with other contraindications to SGLT2 Inhibitors.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Prospective observational study to evaluate the effect of supercritical carbon dioxide processed acellular dermal matrix(SC DERM® Recon) in prosthetic breast reconstructioNeoplasms
KCT0008722Asan Medical Center50
Recruiting
Not Applicable
ong delayed emesis induced by cancer chemotherapy can be suppressed by NK1 receptor antagonist (LODEC-N)
JPRN-jRCT1030230130Seiichiro Kuroda100
Recruiting
Not Applicable
Prospective observational study to evaluate the efficacy of anamorelin on the course of first line chemotherapy in patients with previously-untreated advanced non-small cell lung cancer and cachexia (NEJ050B)on-small cell lung cancer
JPRN-UMIN000050878orth East Japan Study Group (NEJSG)135
Completed
Not Applicable
Prospective observational study to evaluate the efficacy and safety of osimertinib by PK/PD/PGx analysisung Cancer
JPRN-UMIN000029995ational Cancer CEnter200
Completed
Not Applicable
Prospective observational study to evaluate the efficacy and safety of PD-1/PD-L1 antibody by PK/PD/PGx analysis.ung Cancer
JPRN-UMIN000029994ational Cancer Center Hospital210